BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 25748828)

  • 1. A case of hypoglycemia due to illegitimate sexual enhancement medication.
    Kuramoto N; Yabe D; Kurose T; Seino Y
    Diabetes Res Clin Pract; 2015 Apr; 108(1):e8-e10. PubMed ID: 25748828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severe hypoglycaemia associated with ingesting counterfeit medication.
    Chaubey SK; Sangla KS; Suthaharan EN; Tan YM
    Med J Aust; 2010 Jun; 192(12):716-7. PubMed ID: 20565353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Current role of sildenafil in the management of erectile dysfunction].
    Akhvlediani ND; Matyukhov IP
    Urologiia; 2018 May; (2):142-146. PubMed ID: 29901310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outbreaks of severe hypoglycaemia due to illegal sexual enhancement products containing undeclared glibenclamide.
    Chan TY
    Pharmacoepidemiol Drug Saf; 2009 Dec; 18(12):1250-1. PubMed ID: 19937648
    [No Abstract]   [Full Text] [Related]  

  • 5. [Erectile dysfunction, PDE5A inhibitors and melanoma].
    Schmutz JL
    Ann Dermatol Venereol; 2015 Dec; 142(12):800-1. PubMed ID: 26293983
    [No Abstract]   [Full Text] [Related]  

  • 6. Outbreak of hypoglycaemia: sexual enhancement products containing oral hypoglycaemic agent.
    Poon WT; Lam YH; Lee HH; Ching CK; Chan WT; Chan SS; Lai CK; Tse ML; Chan AY; Mak TW
    Hong Kong Med J; 2009 Jun; 15(3):196-200. PubMed ID: 19494375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Melanoma, Viagra, and PDE5 Inhibitors: Proliferation and Metastasis.
    Houslay MD
    Trends Cancer; 2016 Apr; 2(4):163-165. PubMed ID: 28741569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Case Report: Consecutive Cranial Neuropathies Following the Use of Phosphodiesterase-5 Inhibitors.
    van Landingham SW; Singman EL
    Am Orthopt J; 2015; 65():109-14. PubMed ID: 26564936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolonged hypoglycemic crisis associated with glyburide.
    Sills MN; Ogu CC; Maxa J
    Pharmacotherapy; 1997; 17(6):1338-40. PubMed ID: 9399622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [PDE-5 inhibitors: patients preferences].
    Efremov EA; Kasatonova EV; Melnik YI; Nikushina AA
    Urologiia; 2017 Jul; (3):120-126. PubMed ID: 28845950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PDE-5 inhibitors: clinical points.
    Doumas M; Lazaridis A; Katsiki N; Athyros V
    Curr Drug Targets; 2015; 16(5):420-6. PubMed ID: 25392015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Dosage forms of sildenafil in the management of erectile dysfunction].
    Grigoryan VA; Gazimiev MA; Demidko YL; Baiduvaliev AM
    Urologiia; 2018 Mar; (1):159-162. PubMed ID: 29634153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An unusual outbreak of hypoglycemia.
    Kao SL; Chan CL; Tan B; Lim CC; Dalan R; Gardner D; Pratt E; Lee M; Lee KO
    N Engl J Med; 2009 Feb; 360(7):734-6. PubMed ID: 19213693
    [No Abstract]   [Full Text] [Related]  

  • 14. Fourth Cranial Nerve Palsy Associated With Sildenafil Citrate.
    Lee Y; Park KA; Oh SY; Min JH; Kim BJ
    J Neuroophthalmol; 2021 Mar; 41(1):e79-e80. PubMed ID: 32235216
    [No Abstract]   [Full Text] [Related]  

  • 15. Risk-benefit assessment of oral phosphodiesterase type 5 inhibitors for treatment of erectile dysfunction: a multiple criteria decision analysis.
    Hsu JC; Tang DH; Lu CY
    Int J Clin Pract; 2015 Apr; 69(4):436-43. PubMed ID: 25311239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [SILDENAFIL CITRATE DOSE ADJUSTMENT FOR MEN WITH ERECTILE DYSFUNCTION: PERSONALIZED APPROACH].
    Korneev IA
    Urologiia; 2015; (4):108, 110-1. PubMed ID: 26665776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Transient Colorblindness With Sildenafil and Tadalafil.
    Rosen SM; Kaja S; De Alba F
    JAMA Ophthalmol; 2019 Jan; 137(1):117-118. PubMed ID: 30286227
    [No Abstract]   [Full Text] [Related]  

  • 18. Characteristics and time course of severe glimepiride- versus glibenclamide-induced hypoglycaemia.
    Holstein A; Plaschke A; Hammer C; Egberts EH
    Eur J Clin Pharmacol; 2003 Jun; 59(2):91-7. PubMed ID: 12698302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms underlie the proconvulsant effects of sildenafil.
    Zirak MR; Rahimian R; Mousavizadeh K; Dehpour AR
    Biomed Pharmacother; 2021 Feb; 134():111142. PubMed ID: 33360157
    [No Abstract]   [Full Text] [Related]  

  • 20. Hypoglycemia in hospitalized patients treated with sulfonylureas.
    Deusenberry CM; Coley KC; Korytkowski MT; Donihi AC
    Pharmacotherapy; 2012 Jul; 32(7):613-7. PubMed ID: 22570146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.